{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T21:54:27Z","timestamp":1785275667287,"version":"3.55.0"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"4","funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000993","name":"Battelle Memorial Institute","doi-asserted-by":"publisher","award":["HHSN272200700016I"],"award-info":[{"award-number":["HHSN272200700016I"]}],"id":[{"id":"10.13039\/100000993","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Laulima Government Solutions","award":["HHSN272201800013C"],"award-info":[{"award-number":["HHSN272201800013C"]}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Leidos Biomedical Research"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012728","name":"Frederick National Laboratory for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012728","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Ebola virus (EBOV) disease (EVD) is one of the most severe and fatal viral hemorrhagic fevers and appears to mimic many clinical and laboratory manifestations of hemophagocytic lymphohistiocytosis syndrome (HLS), also known as macrophage activation syndrome. However, a clear association is yet to be firmly established for effective host-targeted, immunomodulatory therapeutic approaches to improve outcomes in patients with severe EVD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Twenty-four rhesus monkeys were exposed intramuscularly to the EBOV Kikwit isolate and euthanized at prescheduled time points or when they reached the end-stage disease criteria. Three additional monkeys were mock-exposed and used as uninfected controls.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>EBOV-exposed monkeys presented with clinicopathologic features of HLS, including fever, multiple organomegaly, pancytopenia, hemophagocytosis, hyperfibrinogenemia with disseminated intravascular coagulation, hypertriglyceridemia, hypercytokinemia, increased concentrations of soluble CD163 and CD25 in serum, and the loss of activated natural killer cells.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Our data suggest that EVD in the rhesus macaque model mimics pathophysiologic features of HLS\/macrophage activation syndrome. Hence, regulating inflammation and immune function might provide an effective treatment for controlling the pathogenesis of acute EVD.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/infdis\/jiad203","type":"journal-article","created":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T13:32:04Z","timestamp":1686317524000},"page":"371-382","source":"Crossref","is-referenced-by-count":9,"title":["Ebola Virus Disease Features Hemophagocytic Lymphohistiocytosis\/Macrophage Activation Syndrome in the Rhesus Macaque Model"],"prefix":"10.1093","volume":"228","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-3260-3848","authenticated-orcid":false,"given":"David X","family":"Liu","sequence":"first","affiliation":[{"name":"Integrated Research Facility at Fort Detrick, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick , Frederick, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bapi","family":"Pahar","sequence":"additional","affiliation":[{"name":"Integrated Research Facility at Fort Detrick, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick , Frederick, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy K","family":"Cooper","sequence":"additional","affiliation":[{"name":"Integrated Research Facility at Fort Detrick, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick , Frederick, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna L","family":"Perry","sequence":"additional","affiliation":[{"name":"Integrated Research Facility at Fort Detrick, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick , Frederick, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanbin","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Comparative Pathology, Tulane National Primate Research Center , Covington, Louisiana , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis M","family":"Huzella","sequence":"additional","affiliation":[{"name":"Integrated Research Facility at Fort Detrick, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick , Frederick, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricky D","family":"Adams","sequence":"additional","affiliation":[{"name":"Integrated Research Facility at Fort Detrick, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick , Frederick, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda M W","family":"Hischak","sequence":"additional","affiliation":[{"name":"Integrated Research Facility at Fort Detrick, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick , Frederick, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randy J","family":"Hart","sequence":"additional","affiliation":[{"name":"Integrated Research Facility at Fort Detrick, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick , Frederick, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Bernbaum","sequence":"additional","affiliation":[{"name":"Integrated Research Facility at Fort Detrick, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick , Frederick, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deja","family":"Rivera","sequence":"additional","affiliation":[{"name":"Integrated Research Facility at Fort Detrick, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick , Frederick, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Anthony","sequence":"additional","affiliation":[{"name":"Integrated Research Facility at Fort Detrick, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick , Frederick, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa St","family":"Claire","sequence":"additional","affiliation":[{"name":"Integrated Research Facility at Fort Detrick, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick , Frederick, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Byrum","sequence":"additional","affiliation":[{"name":"Integrated Research Facility at Fort Detrick, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick , Frederick, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Cooper","sequence":"additional","affiliation":[{"name":"Integrated Research Facility at Fort Detrick, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick , Frederick, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Reeder","sequence":"additional","affiliation":[{"name":"Integrated Research Facility at Fort Detrick, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick , Frederick, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Kurtz","sequence":"additional","affiliation":[{"name":"Integrated Research Facility at Fort Detrick, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick , Frederick, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyra","family":"Hadley","sequence":"additional","affiliation":[{"name":"Integrated Research Facility at Fort Detrick, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick , Frederick, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiro","family":"Wada","sequence":"additional","affiliation":[{"name":"Integrated Research Facility at Fort Detrick, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick , Frederick, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Crozier","sequence":"additional","affiliation":[{"name":"Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research , Frederick, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Worwa","sequence":"additional","affiliation":[{"name":"Integrated Research Facility at Fort Detrick, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick , Frederick, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard S","family":"Bennett","sequence":"additional","affiliation":[{"name":"Integrated Research Facility at Fort Detrick, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick , Frederick, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis","family":"Warren","sequence":"additional","affiliation":[{"name":"Integrated Research Facility at Fort Detrick, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick , Frederick, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0824-2667","authenticated-orcid":false,"given":"Michael R","family":"Holbrook","sequence":"additional","affiliation":[{"name":"Integrated Research Facility at Fort Detrick, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick , Frederick, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie S","family":"Schmaljohn","sequence":"additional","affiliation":[{"name":"Integrated Research Facility at Fort Detrick, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick , Frederick, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa E","family":"Hensley","sequence":"additional","affiliation":[{"name":"Integrated Research Facility at Fort Detrick, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick , Frederick, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,6,4]]},"reference":[{"key":"2023081611083552500_jiad203-B1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev-pathol-020117-043625","article-title":"Hemophagocytic lymphohistiocytosis","volume":"13","author":"Al-Samkari","year":"2018","journal-title":"Annu Rev Pathol"},{"key":"2023081611083552500_jiad203-B2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jcv.2012.06.005","article-title":"Hemophagocytosis in dengue: comprehensive report of six cases","volume":"55","author":"Tan","year":"2012","journal-title":"J Clin Virol"},{"key":"2023081611083552500_jiad203-B3","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3201\/eid2502.181326","article-title":"Macrophage activation marker soluble CD163 associated with fatal and severe Ebola virus disease in humans","volume":"25","author":"McElroy","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"2023081611083552500_jiad203-B4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2147\/JBM.S46255","article-title":"Hemophagocytic lymphohistiocytosis: review of etiologies and management","volume":"5","author":"George","year":"2014","journal-title":"J Blood Med"},{"key":"2023081611083552500_jiad203-B5","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1146\/annurev-pathol-052016-100506","article-title":"The pathogenesis of Ebola virus disease","volume":"12","author":"Baseler","year":"2017","journal-title":"Annu Rev Pathol"},{"key":"2023081611083552500_jiad203-B6","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/infdis\/jiu088","article-title":"Ebola hemorrhagic fever: novel biomarker correlates of clinical outcome","volume":"210","author":"McElroy","year":"2014","journal-title":"J Infect Dis"},{"key":"2023081611083552500_jiad203-B7","first-page":"4","article-title":"Ebola virus disease has features of hemophagocytic lymphohistiocytosis syndrome","volume":"2","author":"Van der Ven","year":"2015","journal-title":"Front Med (Lausanne)"},{"key":"2023081611083552500_jiad203-B8","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.137260","article-title":"Immunologic timeline of Ebola virus disease and recovery in humans","volume":"5","author":"McElroy","year":"2020","journal-title":"JCI Insight"},{"key":"2023081611083552500_jiad203-B9","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/S0002-9440(10)63591-2","article-title":"Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection","volume":"163","author":"Geisbert","year":"2003","journal-title":"Am J Pathol"},{"key":"2023081611083552500_jiad203-B10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/path.1711250303","article-title":"The pathology of experimental Ebola virus infection in monkeys","volume":"125","author":"Baskerville","year":"1978","journal-title":"J Pathol"},{"key":"2023081611083552500_jiad203-B11","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1177\/0300985812469636","article-title":"Pathology of experimental aerosol Zaire ebolavirus infection in rhesus macaques","volume":"50","author":"Twenhafel","year":"2013","journal-title":"Vet Pathol"},{"key":"2023081611083552500_jiad203-B12","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3390\/v12070753","article-title":"Kikwit Ebola virus disease progression in the rhesus monkey animal model","volume":"12","author":"Bennett","year":"2020","journal-title":"Viruses"},{"key":"2023081611083552500_jiad203-B13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ajpath.2021.09.009","article-title":"Expanded histopathology and tropism of Ebola virus in the rhesus macaque model: potential for sexual transmission, altered adrenomedullary hormone production, and early viral replication in liver","volume":"192","author":"Liu","year":"2022","journal-title":"Am J Pathol"},{"key":"2023081611083552500_jiad203-B14","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1093\/infdis\/jiaa304","article-title":"Peripheral neuronopathy associated with Ebola virus infection in rhesus macaques: a possible cause of neurological signs and symptoms in human Ebola patients","volume":"222","author":"Liu","year":"2020","journal-title":"J Infect Dis"},{"key":"2023081611083552500_jiad203-B15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1006\/viro.2001.0836","article-title":"Monocyte-derived human macrophages and peripheral blood mononuclear cells infected with Ebola virus secrete MIP-1\u03b1 and TNF-\u03b1 and inhibit poly-IC-induced IFN-\u03b1 in vitro","volume":"284","author":"Gupta","year":"2001","journal-title":"Virology"},{"key":"2023081611083552500_jiad203-B16","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00845-17","article-title":"Ebola virus binding to tim-1 on T lymphocytes induces a cytokine storm","volume":"8","author":"Younan","year":"2017","journal-title":"mBio"},{"key":"2023081611083552500_jiad203-B17","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1089\/vim.2004.17.390","article-title":"Depletion of peripheral blood T lymphocytes and NK cells during the course of Ebola hemorrhagic fever in cynomolgus macaques","volume":"17","author":"Reed","year":"2004","journal-title":"Viral Immunol"},{"key":"2023081611083552500_jiad203-B18","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3389\/fimmu.2011.00088","article-title":"Activation of natural killer cells during microbial infections","volume":"2","author":"Horowitz","year":"2012","journal-title":"Front Immunol"},{"key":"2023081611083552500_jiad203-B19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fimmu.2019.00119","article-title":"The immunology of macrophage activation syndrome","volume":"10","author":"Crayne","year":"2019","journal-title":"Front Immunol"},{"key":"2023081611083552500_jiad203-B20","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.hoc.2015.06.009","article-title":"Hemophagocytic lymphohistiocytosis in adults","volume":"29","author":"Campo","year":"2015","journal-title":"Hematol Oncol Clin North Am"},{"key":"2023081611083552500_jiad203-B21","doi-asserted-by":"crossref","first-page":"e2858","DOI":"10.1371\/journal.pntd.0002858","article-title":"The role of platelets in the pathogenesis of viral hemorrhagic fevers","volume":"8","author":"Zapata","year":"2014","journal-title":"PloS Negl Trop Dis"},{"key":"2023081611083552500_jiad203-B22","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1182\/blood-2005-05-1980","article-title":"Severe imbalance of IL-18\/IL-18BP in patients with secondary hemophagocytic syndrome","volume":"106","author":"Mazodier","year":"2005","journal-title":"Blood"},{"key":"2023081611083552500_jiad203-B23","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.cytogfr.2014.10.001","article-title":"Hemophagocytic lymphohistiocytosis (HLH): a heterogeneous spectrum of cytokine-driven immune disorders","volume":"26","author":"Brisse","year":"2015","journal-title":"Cytokine Growth Factor Rev"},{"key":"2023081611083552500_jiad203-B24","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1365-2249.2002.01800.x","article-title":"Inflammatory responses in Ebola virus-infected patients","volume":"128","author":"Baize","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"2023081611083552500_jiad203-B25","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0165-2478(01)00327-3","article-title":"Proinflammatory response during Ebola virus infection of primate models: possible involvement of the tumor necrosis factor receptor superfamily","volume":"80","author":"Hensley","year":"2002","journal-title":"Immunol Lett"},{"issue":"suppl 3","key":"2023081611083552500_jiad203-B26","doi-asserted-by":"crossref","first-page":"S991","DOI":"10.1093\/infdis\/jir336","article-title":"Host response dynamics following lethal infection of rhesus macaques with Zaire ebolavirus","volume":"204","author":"Ebihara","year":"2011","journal-title":"J Infect Dis"},{"key":"2023081611083552500_jiad203-B27","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1002\/art.37958","article-title":"Interferon-gamma mediates anemia but is dispensable for fulminant Toll-like receptor 9-induced macrophage activation syndrome and hemophagocytosis in mice","volume":"65","author":"Canna","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2023081611083552500_jiad203-B28","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S2213-2600(20)30124-7","article-title":"Subphenotypes in critical care: translation into clinical practice","volume":"8","author":"Reddy","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2023081611083552500_jiad203-B29","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1136\/ard-2022-223739","article-title":"Efficacy and safety of emapalumab in macrophage activation syndrome","volume":"82","author":"De Benedetti","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"2023081611083552500_jiad203-B30","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1182\/blood.2021014860","article-title":"A study of ruxolitinib response-based stratified treatment for pediatric hemophagocytic lymphohistiocytosis","volume":"139","author":"Zhang","year":"2022","journal-title":"Blood"},{"key":"2023081611083552500_jiad203-B31","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/14397595.2021.1899565","article-title":"Macrophage activation syndrome in patients with adult-onset Still's disease under tocilizumab treatment: a single-center observational study","volume":"32","author":"Yamabe","year":"2022","journal-title":"Mod Rheumatol"},{"key":"2023081611083552500_jiad203-B32","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12969-021-00585-3","article-title":"Intravenous administration of anakinra in children with macrophage activation syndrome","volume":"19","author":"Phadke","year":"2021","journal-title":"Pediatr Rheumatol Online J"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiad203\/50830054\/jiad203.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/228\/4\/371\/51115580\/jiad203.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/228\/4\/371\/51115580\/jiad203.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T11:09:26Z","timestamp":1692184166000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/228\/4\/371\/7190197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,4]]},"references-count":32,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,6,4]]},"published-print":{"date-parts":[[2023,8,16]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiad203","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,8,15]]},"published":{"date-parts":[[2023,6,4]]}}}